IL208334A - Methods for Creating Human Cardiovascular Origin Cells of Cardiomyocytes, Endothelial Cells, and Vascular Muscle Cells - Google Patents

Methods for Creating Human Cardiovascular Origin Cells of Cardiomyocytes, Endothelial Cells, and Vascular Muscle Cells

Info

Publication number
IL208334A
IL208334A IL208334A IL20833410A IL208334A IL 208334 A IL208334 A IL 208334A IL 208334 A IL208334 A IL 208334A IL 20833410 A IL20833410 A IL 20833410A IL 208334 A IL208334 A IL 208334A
Authority
IL
Israel
Prior art keywords
cells
cardiomyocytes
methods
smooth muscle
vascular smooth
Prior art date
Application number
IL208334A
Other languages
English (en)
Hebrew (he)
Other versions
IL208334A0 (en
Inventor
Gordon Keller
Lei Yang
Steven Kattman
Original Assignee
Icahn School Med Mount Sinai
Gordon Keller
Lei Yang
Steven Kattman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icahn School Med Mount Sinai, Gordon Keller, Lei Yang, Steven Kattman filed Critical Icahn School Med Mount Sinai
Publication of IL208334A0 publication Critical patent/IL208334A0/en
Publication of IL208334A publication Critical patent/IL208334A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/165—Vascular endothelial growth factor [VEGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL208334A 2008-03-27 2010-09-21 Methods for Creating Human Cardiovascular Origin Cells of Cardiomyocytes, Endothelial Cells, and Vascular Muscle Cells IL208334A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4004908P 2008-03-27 2008-03-27
PCT/US2009/038220 WO2009120762A2 (en) 2008-03-27 2009-03-25 Human cardiovascular progenitor cells

Publications (2)

Publication Number Publication Date
IL208334A0 IL208334A0 (en) 2010-12-30
IL208334A true IL208334A (en) 2015-09-24

Family

ID=41114664

Family Applications (2)

Application Number Title Priority Date Filing Date
IL208334A IL208334A (en) 2008-03-27 2010-09-21 Methods for Creating Human Cardiovascular Origin Cells of Cardiomyocytes, Endothelial Cells, and Vascular Muscle Cells
IL240870A IL240870B (en) 2008-03-27 2015-08-27 Human cardiovascular progenitor cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL240870A IL240870B (en) 2008-03-27 2015-08-27 Human cardiovascular progenitor cells

Country Status (8)

Country Link
US (2) US10077428B2 (https=)
EP (1) EP2273996B8 (https=)
JP (1) JP5801187B2 (https=)
AU (1) AU2009228354B2 (https=)
CA (1) CA2717962C (https=)
DK (1) DK2273996T3 (https=)
IL (2) IL208334A (https=)
WO (1) WO2009120762A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103627671A (zh) * 2007-01-30 2014-03-12 佐治亚大学研究基金会 产生中内胚层细胞及多能游走细胞的方法与细胞群及用途
EP2490701B9 (en) * 2009-10-19 2017-11-15 Cellular Dynamics International, Inc. Cardiomyocyte production
WO2011090684A2 (en) * 2009-12-29 2011-07-28 Cornell University Methods for developing endothelial cells from pluripotent cells and endothelial cells derived
US20120301445A1 (en) * 2010-01-26 2012-11-29 Universite Libre De Bruxelles Tools for isolating and following cardiovascular progenitor cells
US9273286B2 (en) 2010-06-13 2016-03-01 Institute Of Biophysics, Chinese Academy Of Sciences Methods and compositions for preparing cardiomyocytes from stem cells and uses thereof
US9181529B2 (en) 2010-10-19 2015-11-10 Cellular Dynamics International, Inc. Titration of differentiation medium components
WO2012112776A2 (en) * 2011-02-16 2012-08-23 Salk Institute For Biological Studies Robust and efficient differentiation of human pluripotent stem cells to multipotent vascular progenitors
JP6185907B2 (ja) 2011-03-30 2017-08-23 セルラー ダイナミクス インターナショナル， インコーポレイテッド 神経分化のための多能性幹細胞の予備刺激
GB201109882D0 (en) 2011-06-13 2011-07-27 Cambridge Entpr Ltd Population of smooth muscle cells of specific embryonic lineages
GB201121101D0 (en) * 2011-12-08 2012-01-18 Nhs Blood & Transplant A method of preparing isolated cells and uses
US9764063B2 (en) * 2012-03-15 2017-09-19 Iheart Japan Corporation Method for producing mixed cell population of cardiomyocytes and vascular cells from induced pluripotent stem cell
CN104508121B (zh) * 2012-07-23 2018-01-19 中国科学院生物物理研究所 体外诱导多能干细胞分化为心室肌细胞的方法
WO2014192925A1 (ja) * 2013-05-31 2014-12-04 ｉＨｅａｒｔ Ｊａｐａｎ株式会社 効率的な内皮細胞の誘導方法
WO2014197421A1 (en) 2013-06-05 2014-12-11 Biotime, Inc. Compositions and methods for induced tissue regeneration in mammalian species
NZ716860A (en) * 2013-09-13 2022-07-01 Univ Health Network Methods and compositions for generating epicardium cells
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
GB201412554D0 (en) * 2014-07-15 2014-08-27 Cambridge Entpr Ltd In vitro mesodermal differentiation
CA2976283C (en) 2015-02-17 2022-04-26 University Health Network Methods for making and using sinoatrial node-like pacemaker cardiomyocytes and ventricular-like cardiomyocytes
CA3202332A1 (en) 2015-12-07 2017-06-15 Agex Therapeutics, Inc. Methods for the re-derivation of diverse pluripotent stem cell-derived brown fat cells
US10612002B2 (en) 2016-02-19 2020-04-07 University Of Washington Human pluripotent stem cell derived endocardial endothelium
WO2017147381A1 (en) * 2016-02-25 2017-08-31 The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone Generation of expandable cardiovascular progenitor cells
CN116096388A (zh) * 2020-05-08 2023-05-09 大学健康网络 用于制备和使用心内膜细胞的方法和组合物
EP4508645A1 (en) 2022-04-15 2025-02-19 Aspen Neuroscience, Inc. Methods of classifying the differentiation state of cells and related compositions of differentiated cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874301A (en) 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5919449A (en) 1995-05-30 1999-07-06 Diacrin, Inc. Porcine cardiomyocytes and their use in treatment of insufficient cardiac function
US20050021439A1 (en) 1999-04-09 2005-01-27 Pinga Louis J. Arcade casino and home investment system
WO2003006950A2 (en) 2001-07-12 2003-01-23 Geron Corporation Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
US20030082153A1 (en) 2001-10-22 2003-05-01 The Government Of The United States Of America Stem cells that transform to beating cardiomyocytes
US20060003446A1 (en) 2002-05-17 2006-01-05 Gordon Keller Mesoderm and definitive endoderm cell populations
WO2004094610A2 (en) 2003-04-21 2004-11-04 Baylor College Of Medicine Wnt as a factor for cardiac myogenesis
US7452718B2 (en) * 2004-03-26 2008-11-18 Geron Corporation Direct differentiation method for making cardiomyocytes from human embryonic stem cells
US20050214938A1 (en) * 2004-03-26 2005-09-29 Gold Joseph D Cardiac bodies: clusters of spontaneously contracting cells for regenerating cardiac function
CA2611809C (en) 2005-06-22 2018-06-19 Geron Corporation Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
CA2620567A1 (en) 2005-06-23 2007-01-04 Mount Sinai School Of Medicine Of New York University Cardiomyocyte cell populations

Also Published As

Publication number Publication date
EP2273996B8 (en) 2017-04-26
US10947506B2 (en) 2021-03-16
EP2273996A4 (en) 2012-02-15
JP5801187B2 (ja) 2015-10-28
WO2009120762A3 (en) 2009-12-30
DK2273996T3 (en) 2017-03-27
EP2273996B1 (en) 2017-02-22
IL208334A0 (en) 2010-12-30
EP2273996A2 (en) 2011-01-19
CA2717962C (en) 2019-05-14
US10077428B2 (en) 2018-09-18
CA2717962A1 (en) 2009-10-01
AU2009228354A1 (en) 2009-10-01
IL240870B (en) 2019-08-29
IL240870A0 (en) 2015-10-29
JP2011517563A (ja) 2011-06-16
AU2009228354B2 (en) 2015-01-22
US20180362931A1 (en) 2018-12-20
US20090269314A1 (en) 2009-10-29
WO2009120762A2 (en) 2009-10-01

Similar Documents

Publication Publication Date Title
IL208334A (en) Methods for Creating Human Cardiovascular Origin Cells of Cardiomyocytes, Endothelial Cells, and Vascular Muscle Cells
IL276146A (en) Laboratory methods for increasing the vitality of the cells of the immune system
IL207449A0 (en) Genetically modified cyanobacteria, methods of producing the same and methods of producing ethanol utilizing the same
EG27167A (en) Microemulsifiers and methods of making and using same
EP2491174A4 (en) POROUS SUPPORTED ARTICLES AND MANUFACTURING METHOD THEREFOR
IL216044A0 (en) Method of expanding human hepatocytes in vivo
EP2332071A4 (en) OBJECTIVE MODEL OF APPARENT AGE, METHODS AND USE
EP2118268A4 (en) USE OF AN IN VITRO HEMODYNAMIC ENDOTHELIAL / SOFT MUSCLE CELL CULTURE MODEL FOR IDENTIFYING NEW THERAPEUTIC OBJECTIVES FOR VASCULAR DISEASE
EP2334804A4 (en) COCULTURAL COMPOSITIONS AND METHODS
EP2405755A4 (en) METHOD AND COMPOSITIONS FOR TREATING METABOLISM AND CARDIOVASCULAR DISEASES
EP2490889A4 (en) POROUS MULTILAYER ARTICLES AND METHODS OF MANUFACTURE
IL208082A (en) In vitro preparation of cardiovascular progenitor cells from the upper mammalian embryonic stem cells
EP2393915A4 (en) PROCESS FOR THE PREPARATION OF PRECURSOR CELLS FROM DIFFERENTIATED CELLS
EP2367866A4 (en) POLYESTER, MANUFACTURING METHOD THEREFOR AND USE
EP2287230A4 (en) DOCETAXELPOLYMER DERIVATIVE, METHOD FOR ITS PRODUCTION AND USE
IL215856A0 (en) Compositions and methods for treatment of cardiovascular disease
GB0811856D0 (en) Magnetic microbubbles, methods of preparing them and their uses
GB2483311B (en) Method of producing fermented tea drink
EP2250254A4 (en) PROCESS FOR PRODUCING PROGENITOR CELLS FROM DIFFERENTIATED CELLS
EP2427767A4 (en) MEANS AND METHODS FOR RECOGNIZING THE DEVELOPMENT OF CARDIOVASCULAR DISEASE IN AN INDIVIDUAL
GB0800324D0 (en) Polymer and preparation process
SI2491005T1 (sl) Uporaba 4-(etil(dimetil)amonio)butanoata pri zdravljenju bolezni srca in oĺ˝ilja
GB2463959B (en) Electrolyte membrane, methods of manufacture thereof and articles comprising the same
EP2258721A4 (en) POLYETHYLENE-GLYCOSYLATED LACTOFERRINE COMPLEX AND METHOD FOR THE PRODUCTION THEREOF
PL2318020T3 (pl) Immunosupresyjne komórki krwi i sposób ich wytwarzania

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed